Out of 630 patients treated by radical prostatectomy at our institution since 1969,100 are now at risk for more than 15 years. Of these 100 patients, 68 had a pathologically organ-confined tumor (stage pT(2)pN(0)) and 23 had capsular penetration or seminal vesicle involvement (stage pT(3)pN(0)). In 9 cases, lymph node metastases (stage pT(2-3)pN(1-2) were detected. The observed overall 15-year survival rates were found to be 55.9 (stage pT(2)), 47.8 (stage pT(3)) and 22.2% (stage pT(2-3)pN(1_2), respectively. The corresponding 15-year tumorrelated survival rates were 80.9, 73.9 and 55.6%, respectively. Patients with stage pT(2) or pT(3) tumors following radical prostatectomy were shown to have a survival expectancy equal to the male age-matched control population. These observed 15-year follow-up data delineate radical prostatectomy to be the best way to achieve long-term disease-free survival, if not cure, in patients with clinically localized prostate cancer.

Keywords:
Prostate cancer, Radical prostatectomy, Long-term results
This content is only available via PDF.
1995
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.